OOIR: Observatory of International Research

Papers

(The TQCC of Journal of the Peripheral Nervous System is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
	66
	49
Abstracts	38
	31
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”	27
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	26
PNS Abstracts 2023	23
Toxic medications in Charcot–Marie–Tooth patients: A systematic review	21
Identifying Predictors of Idiopathic Small‐Fiber Neuropathy in Adolescent Patients With Chronic Pain	19
	19
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)	18
Nerve ultrasound as a screening tool for inherited sensory neuronopathy	17
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort	17
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice	16
Ofatumumab for treating autoimmune nodopathy	16
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders	16
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study	15
Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT	15
Variability in Conduction Block Definitions Affects the Sensitivity of Diagnostic Criteria for Multifocal Motor Neuropathy	15
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy	14
Issue Information	14
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy	14
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)	13
Issue Information	12
Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology	12

Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials	12
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy	11
IgM anti‐MAG^± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei	11
A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state‐of‐the‐art tracking methods	11
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study	11
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China	11
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version	11
Peter James Dyck: In Memoriam	10
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency	10
A Novel Case of Nerve Biopsy Proven Wild Type Transthyretin (TTR) Amyloidosis	10
Frequent De Novo Mutations in Korean Patients With Charcot–Marie–Tooth Disease	10
Issue Information	10
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy	9
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia	9
Issue Information	9
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A	9
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision	9
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis	9
Rethinking Neuropathy in TTC19 Mutations: The Need for Broader Differential Diagnosis	9
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy	8
	8
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes	8
	8
Issue Information	8
Issue Information	8
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”	7
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers	7
Issue Information	7
Intravenous Immunoglobulin Elevates Regulatory T Cells in Guillain‐Barré Syndrome: A Potential Biomarker of Therapeutic Response	7
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)	7
ABSTRACT	6
	6
	6
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po	6
The autoimmune vulnerability of the node of Ranvier	6
Molecular Characterization of Oxaliplatin‐Induced Peripheral Neurotoxicity: The Complex Spectrum of Painful Manifestations	6
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies	5
Correction to “Polyneuropathy in Kidney Transplant Recipients: Accuracy of a New Clinical Diagnostic Scoring System”	5
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy	5
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis	5
VitaminB6levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy	5
Influence of Genomic Ancestry and Other Traditional Risk Factors on the Prevalence of Diabetic Peripheral Neuropathy in Admixed Individuals With Type 1 Diabetes in Brazil: A Pioneer Multicenter Study	5
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease	5
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?	5
	5
Digenesis in Charcot–Marie–Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes	5
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience	5
Acquired Transthyretin Amyloidosis in Domino Liver Transplantation Treated With Gene‐Silencers	5
Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation	4
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis	4

High‐Fat Diet Disrupt Nerve Function by Targeting Schwann Cells	4
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era	4
Issue Information	4
Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort	4
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor	4
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial	4
GDAP1‐Related Charcot–Marie–Tooth Disease: Axonal or Demyelinating Subtype? Autosomal Recessive or Autosomal Dominant Inheritance?	4
Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling	4
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease	4
Genetic and Clinical Features of 10 Families With Hereditary Sensory Neuropathies	4
Phenotypic features of RETREG1‐related hereditary sensory autonomic neuropathy	4
Issue Information	4
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study	4
Anxiety and depression in small fiber neuropathy	4